ALK/CD246: Products

Anaplastic Lymphoma Kinase (ALK), also known as CD246, is a 220 kDa transmembrane glycoprotein that is primarily expressed in the developing nervous system. ALK contains one LDL Receptor (LDLR) class A domain, two meprin/A5-protein/PTPmu (MAM) domains, and a cytoplasmic kinase domain.

"ALK/CD246" has 14 results in Products.
Sort by:
Results Per Page:

Proteome Profiler Human Phospho-RTK Array Kit 

Contains 4 membranes - each spotted in duplicate with 49 different RTK antibodies

Human ALK/CD246 Antibody 

2 Images
IHC, WB

TL 13-112 

Selective ALK Degrader

Human ALK/CD246 Antibody 

WB

Human ALK/CD246 Antibody 

1 Image
ICC/IF

KRCA 0008 

Potent Ack1 and ALK dual inhibitor; orally bioavailable

ASP 3026 

Potent anaplastic lymphoma kinase (ALK) inhibitor; also potent ACK inhibitor

LDN 212854 

Potent bone morphogenetic protein type I (ALK) inhibitor

TL 13-12 

Selective ALK degrader

TL 13-110 

Negative control for TL 13-112 (Cat. No. 6745)

TL 13-22 

Negative control for TL 13-12 (Cat. No. 6744)

Ceritinib 

Highly potent ALK inhibitor; also potently inhibits IR, IGF1R, STK22D and FLT3
page of 1